SlideShare a Scribd company logo
KBI Case Studies
Process Development
Improving Titer
Toolbox for Product Quality Optimization
High Throughput Process Development Using
Microbioreactors
High Cell Density Process
Improving Titer
Toolbox for Product Quality Optimization
High Throughput Process Development Using
Microbioreactors
High Cell Density Process
KBI Case Studies
Process Development
KBI Case Studies | Process Development
Improving Titer
Objective:
● Increase titer compared to the process transferred to KBI
Outcome:
● Through feed and supplement optimization, KBI routinely
improves titer several fold compared to the process
transferred to KBI
KBI Case Studies | Process Development
Improving Titer
Improving Titer
Toolbox for Product Quality Optimization
High Throughput Process Development Using
Microbioreactors
High Cell Density Process
KBI Case Studies
Process Development
KBI Case Studies | Process Development
Objective:
● Modify product quality to match a predetermined target
through use of a toolbox of strategies around raw
materials and process conditions
Outcome:
● KBI has a toolbox of strategies to optimize
galactosylation, fucosylation, mannonse-5, glycation, and
charge distribution
Toolbox for Product Quality Optimization
KBI Case Studies | Process Development
Toolbox for Product Quality Optimization
Improving Titer
Toolbox for Product Quality Optimization
High Throughput Process Development Using
Microbioreactors
High Cell Density Process
KBI Case Studies
Process Development
KBI Case Studies | Process Development
Objective:
● Demonstrate microbioreactor scalability and shorten
process development timeline by using microbioreactors
Outcome:
● KBI has demonstrated scalability of ambr microbioreactors
and has integrated this technology in process development
workflow. Use of microbioreactors can reduce process
development timeline by 1 – 2 months.
High Throughput Process Development Using Microbioreactors
KBI Case Studies | Process Development
High Throughput Process Development Using Microbioreactors
Days Days
ViableCellDensity(10^6cells/mL)
Viability(%)
Improving Titer
Toolbox for Product Quality Optimization
High Throughput Process Development Using
Microbioreactors
High Cell Density Process
KBI Case Studies
Process Development
KBI Case Studies | Process Development
Objective:
● Develop high cell density processes using ATF
Outcome:
● KBI has developed high cell density processes (>100
million cells/mL) with improved viability and product quality
profiles.
High Cell Density Process
KBI Case Studies | Process Development
High Cell Density Process
www.kbibiopharma.com
PO Box 15579
1101 Hamlin Road
Durham, NC 27704
Tel: +1 919 479 9898
Contact Us
KBI Case Studies: Process Development

More Related Content

What's hot

Debottlenecking Manufacturing Capacity Using High Seed Density Production Pro...
Debottlenecking Manufacturing Capacity Using High Seed Density Production Pro...Debottlenecking Manufacturing Capacity Using High Seed Density Production Pro...
Debottlenecking Manufacturing Capacity Using High Seed Density Production Pro...
KBI Biopharma
 
Optimization of Glycosyation & Charge Distribution Through Culture Parameters...
Optimization of Glycosyation & Charge Distribution Through Culture Parameters...Optimization of Glycosyation & Charge Distribution Through Culture Parameters...
Optimization of Glycosyation & Charge Distribution Through Culture Parameters...
KBI Biopharma
 
From Screening to QC: Development Considerations for Octet Methods
From Screening to QC: Development Considerations for Octet MethodsFrom Screening to QC: Development Considerations for Octet Methods
From Screening to QC: Development Considerations for Octet Methods
KBI Biopharma
 
Establishing Improved O2 Supply, Lower dCO2 Built Up and pH Control in Large ...
Establishing Improved O2 Supply, Lower dCO2 Built Up and pH Control in Large ...Establishing Improved O2 Supply, Lower dCO2 Built Up and pH Control in Large ...
Establishing Improved O2 Supply, Lower dCO2 Built Up and pH Control in Large ...
KBI Biopharma
 
Next Generation Recombinant Protein Manufacturing
Next Generation Recombinant Protein ManufacturingNext Generation Recombinant Protein Manufacturing
Next Generation Recombinant Protein Manufacturing
KBI Biopharma
 
Compressed Timelines for Breakthrough Therapies: Impact on Process Characteri...
Compressed Timelines for Breakthrough Therapies: Impact on Process Characteri...Compressed Timelines for Breakthrough Therapies: Impact on Process Characteri...
Compressed Timelines for Breakthrough Therapies: Impact on Process Characteri...
KBI Biopharma
 
Scaling Strategies with Stirred Single-Use Bioreactors from Bench to Clinical...
Scaling Strategies with Stirred Single-Use Bioreactors from Bench to Clinical...Scaling Strategies with Stirred Single-Use Bioreactors from Bench to Clinical...
Scaling Strategies with Stirred Single-Use Bioreactors from Bench to Clinical...
MilliporeSigma
 
Covering a Spectrum of New Product Development Technologies - From Cells to C...
Covering a Spectrum of New Product Development Technologies - From Cells to C...Covering a Spectrum of New Product Development Technologies - From Cells to C...
Covering a Spectrum of New Product Development Technologies - From Cells to C...
KBI Biopharma
 
Implementation of End-to-End Disposable Single Use Systems for Rapid Fermenta...
Implementation of End-to-End Disposable Single Use Systems for Rapid Fermenta...Implementation of End-to-End Disposable Single Use Systems for Rapid Fermenta...
Implementation of End-to-End Disposable Single Use Systems for Rapid Fermenta...
KBI Biopharma
 
Platforms for mAb Commercialization
Platforms for mAb Commercialization Platforms for mAb Commercialization
Platforms for mAb Commercialization
KBI Biopharma
 
Primary Recovery & Harvest Processes for non-mAb Recombinant Proteins
Primary Recovery & Harvest Processes for non-mAb Recombinant ProteinsPrimary Recovery & Harvest Processes for non-mAb Recombinant Proteins
Primary Recovery & Harvest Processes for non-mAb Recombinant Proteins
KBI Biopharma
 
Managing Raw Material Variability Over the Life-cycle of a Molecule
Managing Raw Material Variability Over the Life-cycle of a MoleculeManaging Raw Material Variability Over the Life-cycle of a Molecule
Managing Raw Material Variability Over the Life-cycle of a Molecule
KBI Biopharma
 
Employing ForteBio Octet platform for the development of a dual-binding poten...
Employing ForteBio Octet platform for the development of a dual-binding poten...Employing ForteBio Octet platform for the development of a dual-binding poten...
Employing ForteBio Octet platform for the development of a dual-binding poten...
KBI Biopharma
 
High-throughput and Automated Process Development for Accelerated Biotherapeu...
High-throughput and Automated Process Development for Accelerated Biotherapeu...High-throughput and Automated Process Development for Accelerated Biotherapeu...
High-throughput and Automated Process Development for Accelerated Biotherapeu...
KBI Biopharma
 
Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...
Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...
Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...
KBI Biopharma
 
Integration of Cell Line and Process Development to Expedite Delivery of Bisp...
Integration of Cell Line and Process Development to Expedite Delivery of Bisp...Integration of Cell Line and Process Development to Expedite Delivery of Bisp...
Integration of Cell Line and Process Development to Expedite Delivery of Bisp...
KBI Biopharma
 
A Vaccine Approach against HIV-1, Manufacturing Env proteins: from Bench to B...
A Vaccine Approach against HIV-1, Manufacturing Env proteins: from Bench to B...A Vaccine Approach against HIV-1, Manufacturing Env proteins: from Bench to B...
A Vaccine Approach against HIV-1, Manufacturing Env proteins: from Bench to B...
KBI Biopharma
 
Data Collection on the ProteinSimple Maurice: Driving Compliance with the Emp...
Data Collection on the ProteinSimple Maurice: Driving Compliance with the Emp...Data Collection on the ProteinSimple Maurice: Driving Compliance with the Emp...
Data Collection on the ProteinSimple Maurice: Driving Compliance with the Emp...
KBI Biopharma
 
Orphan Biopharmaceuticals & the CDMO
Orphan Biopharmaceuticals & the CDMOOrphan Biopharmaceuticals & the CDMO
Orphan Biopharmaceuticals & the CDMO
KBI Biopharma
 
Biopharmaceutical Formulation Development CM3 Implementation and Initial Testing
Biopharmaceutical Formulation Development CM3 Implementation and Initial TestingBiopharmaceutical Formulation Development CM3 Implementation and Initial Testing
Biopharmaceutical Formulation Development CM3 Implementation and Initial Testing
KBI Biopharma
 

What's hot (20)

Debottlenecking Manufacturing Capacity Using High Seed Density Production Pro...
Debottlenecking Manufacturing Capacity Using High Seed Density Production Pro...Debottlenecking Manufacturing Capacity Using High Seed Density Production Pro...
Debottlenecking Manufacturing Capacity Using High Seed Density Production Pro...
 
Optimization of Glycosyation & Charge Distribution Through Culture Parameters...
Optimization of Glycosyation & Charge Distribution Through Culture Parameters...Optimization of Glycosyation & Charge Distribution Through Culture Parameters...
Optimization of Glycosyation & Charge Distribution Through Culture Parameters...
 
From Screening to QC: Development Considerations for Octet Methods
From Screening to QC: Development Considerations for Octet MethodsFrom Screening to QC: Development Considerations for Octet Methods
From Screening to QC: Development Considerations for Octet Methods
 
Establishing Improved O2 Supply, Lower dCO2 Built Up and pH Control in Large ...
Establishing Improved O2 Supply, Lower dCO2 Built Up and pH Control in Large ...Establishing Improved O2 Supply, Lower dCO2 Built Up and pH Control in Large ...
Establishing Improved O2 Supply, Lower dCO2 Built Up and pH Control in Large ...
 
Next Generation Recombinant Protein Manufacturing
Next Generation Recombinant Protein ManufacturingNext Generation Recombinant Protein Manufacturing
Next Generation Recombinant Protein Manufacturing
 
Compressed Timelines for Breakthrough Therapies: Impact on Process Characteri...
Compressed Timelines for Breakthrough Therapies: Impact on Process Characteri...Compressed Timelines for Breakthrough Therapies: Impact on Process Characteri...
Compressed Timelines for Breakthrough Therapies: Impact on Process Characteri...
 
Scaling Strategies with Stirred Single-Use Bioreactors from Bench to Clinical...
Scaling Strategies with Stirred Single-Use Bioreactors from Bench to Clinical...Scaling Strategies with Stirred Single-Use Bioreactors from Bench to Clinical...
Scaling Strategies with Stirred Single-Use Bioreactors from Bench to Clinical...
 
Covering a Spectrum of New Product Development Technologies - From Cells to C...
Covering a Spectrum of New Product Development Technologies - From Cells to C...Covering a Spectrum of New Product Development Technologies - From Cells to C...
Covering a Spectrum of New Product Development Technologies - From Cells to C...
 
Implementation of End-to-End Disposable Single Use Systems for Rapid Fermenta...
Implementation of End-to-End Disposable Single Use Systems for Rapid Fermenta...Implementation of End-to-End Disposable Single Use Systems for Rapid Fermenta...
Implementation of End-to-End Disposable Single Use Systems for Rapid Fermenta...
 
Platforms for mAb Commercialization
Platforms for mAb Commercialization Platforms for mAb Commercialization
Platforms for mAb Commercialization
 
Primary Recovery & Harvest Processes for non-mAb Recombinant Proteins
Primary Recovery & Harvest Processes for non-mAb Recombinant ProteinsPrimary Recovery & Harvest Processes for non-mAb Recombinant Proteins
Primary Recovery & Harvest Processes for non-mAb Recombinant Proteins
 
Managing Raw Material Variability Over the Life-cycle of a Molecule
Managing Raw Material Variability Over the Life-cycle of a MoleculeManaging Raw Material Variability Over the Life-cycle of a Molecule
Managing Raw Material Variability Over the Life-cycle of a Molecule
 
Employing ForteBio Octet platform for the development of a dual-binding poten...
Employing ForteBio Octet platform for the development of a dual-binding poten...Employing ForteBio Octet platform for the development of a dual-binding poten...
Employing ForteBio Octet platform for the development of a dual-binding poten...
 
High-throughput and Automated Process Development for Accelerated Biotherapeu...
High-throughput and Automated Process Development for Accelerated Biotherapeu...High-throughput and Automated Process Development for Accelerated Biotherapeu...
High-throughput and Automated Process Development for Accelerated Biotherapeu...
 
Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...
Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...
Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...
 
Integration of Cell Line and Process Development to Expedite Delivery of Bisp...
Integration of Cell Line and Process Development to Expedite Delivery of Bisp...Integration of Cell Line and Process Development to Expedite Delivery of Bisp...
Integration of Cell Line and Process Development to Expedite Delivery of Bisp...
 
A Vaccine Approach against HIV-1, Manufacturing Env proteins: from Bench to B...
A Vaccine Approach against HIV-1, Manufacturing Env proteins: from Bench to B...A Vaccine Approach against HIV-1, Manufacturing Env proteins: from Bench to B...
A Vaccine Approach against HIV-1, Manufacturing Env proteins: from Bench to B...
 
Data Collection on the ProteinSimple Maurice: Driving Compliance with the Emp...
Data Collection on the ProteinSimple Maurice: Driving Compliance with the Emp...Data Collection on the ProteinSimple Maurice: Driving Compliance with the Emp...
Data Collection on the ProteinSimple Maurice: Driving Compliance with the Emp...
 
Orphan Biopharmaceuticals & the CDMO
Orphan Biopharmaceuticals & the CDMOOrphan Biopharmaceuticals & the CDMO
Orphan Biopharmaceuticals & the CDMO
 
Biopharmaceutical Formulation Development CM3 Implementation and Initial Testing
Biopharmaceutical Formulation Development CM3 Implementation and Initial TestingBiopharmaceutical Formulation Development CM3 Implementation and Initial Testing
Biopharmaceutical Formulation Development CM3 Implementation and Initial Testing
 

Similar to KBI Case Studies: Process Development

Brinkmann consultancy Certification- 4 march 2014 - Green Matter
Brinkmann consultancy Certification- 4 march 2014 - Green Matter Brinkmann consultancy Certification- 4 march 2014 - Green Matter
Brinkmann consultancy Certification- 4 march 2014 - Green Matter
Boris de Jong
 
Stabicon-Corporate presentation
Stabicon-Corporate presentationStabicon-Corporate presentation
Stabicon-Corporate presentation
Stabicon Life Sciences Pvt. Ltd
 
Optimize Your Process Validation Package
Optimize Your Process Validation PackageOptimize Your Process Validation Package
Optimize Your Process Validation Package
Merck Life Sciences
 
Process Development for Cell Therapy and Viral Gene Therapy
Process Development for Cell Therapy and Viral Gene TherapyProcess Development for Cell Therapy and Viral Gene Therapy
Process Development for Cell Therapy and Viral Gene Therapy
MilliporeSigma
 
Process Development for Cell Therapy and Viral Gene Therapy
Process Development for Cell Therapy and Viral Gene TherapyProcess Development for Cell Therapy and Viral Gene Therapy
Process Development for Cell Therapy and Viral Gene Therapy
Merck Life Sciences
 
Resume_TRACEY RICHARDSON_Word 97-2003
Resume_TRACEY RICHARDSON_Word 97-2003Resume_TRACEY RICHARDSON_Word 97-2003
Resume_TRACEY RICHARDSON_Word 97-2003Tracey Richardson
 
Formulation Development Services
Formulation Development ServicesFormulation Development Services
Formulation Development Services
Kemwell Biopharma
 
Getting Biopharmaceutical Production Processes Right the First Time
Getting Biopharmaceutical Production Processes Right the First TimeGetting Biopharmaceutical Production Processes Right the First Time
Getting Biopharmaceutical Production Processes Right the First Time
KBI Biopharma
 
Understanding and Controlling Bioprocess Variation | Parker domnick hunter
Understanding and Controlling Bioprocess Variation | Parker domnick hunterUnderstanding and Controlling Bioprocess Variation | Parker domnick hunter
Understanding and Controlling Bioprocess Variation | Parker domnick hunter
Parker Hannifin Corporation
 
Growing Food Businesses - Dr Lesley MacLeod
Growing Food Businesses - Dr Lesley MacLeodGrowing Food Businesses - Dr Lesley MacLeod
Growing Food Businesses - Dr Lesley MacLeod
Dairy Innovation Australia
 
Sartorius Cell Line Development
Sartorius Cell Line Development Sartorius Cell Line Development
Sartorius Cell Line Development
Raymond Goyco, III
 
Bioeconomy Cluster Builder: Industrial Applications of Biomass and Processing...
Bioeconomy Cluster Builder: Industrial Applications of Biomass and Processing...Bioeconomy Cluster Builder: Industrial Applications of Biomass and Processing...
Bioeconomy Cluster Builder: Industrial Applications of Biomass and Processing...
KTN
 
Auditing of capsule, sterile production and packaging
Auditing of capsule, sterile production and packaging Auditing of capsule, sterile production and packaging
Auditing of capsule, sterile production and packaging
MittalRohit2
 
Karen cash resume_qc08262017
Karen cash resume_qc08262017Karen cash resume_qc08262017
Karen cash resume_qc08262017
Karen J. Cash
 
Chap16managingqualityandproductivity 120510232225-phpapp02
Chap16managingqualityandproductivity 120510232225-phpapp02Chap16managingqualityandproductivity 120510232225-phpapp02
Chap16managingqualityandproductivity 120510232225-phpapp02
Pimsat.University.Karachi
 
Chap 16 managing quality and productivity
Chap 16 managing quality and productivityChap 16 managing quality and productivity
Chap 16 managing quality and productivityMemoona Qadeer
 
Industrial biotechnologies 5 b
Industrial biotechnologies 5 bIndustrial biotechnologies 5 b
Industrial biotechnologies 5 b
lag63
 
BIOCNG PLANT.pdf
BIOCNG PLANT.pdfBIOCNG PLANT.pdf
BIOCNG PLANT.pdf
DILIP RAJA KOLLI
 

Similar to KBI Case Studies: Process Development (20)

Brinkmann consultancy Certification- 4 march 2014 - Green Matter
Brinkmann consultancy Certification- 4 march 2014 - Green Matter Brinkmann consultancy Certification- 4 march 2014 - Green Matter
Brinkmann consultancy Certification- 4 march 2014 - Green Matter
 
Stabicon-Corporate presentation
Stabicon-Corporate presentationStabicon-Corporate presentation
Stabicon-Corporate presentation
 
Optimize Your Process Validation Package
Optimize Your Process Validation PackageOptimize Your Process Validation Package
Optimize Your Process Validation Package
 
Process Development for Cell Therapy and Viral Gene Therapy
Process Development for Cell Therapy and Viral Gene TherapyProcess Development for Cell Therapy and Viral Gene Therapy
Process Development for Cell Therapy and Viral Gene Therapy
 
Process Development for Cell Therapy and Viral Gene Therapy
Process Development for Cell Therapy and Viral Gene TherapyProcess Development for Cell Therapy and Viral Gene Therapy
Process Development for Cell Therapy and Viral Gene Therapy
 
Resume_TRACEY RICHARDSON_Word 97-2003
Resume_TRACEY RICHARDSON_Word 97-2003Resume_TRACEY RICHARDSON_Word 97-2003
Resume_TRACEY RICHARDSON_Word 97-2003
 
Formulation Development Services
Formulation Development ServicesFormulation Development Services
Formulation Development Services
 
MCS
MCS MCS
MCS
 
JCR 2017
JCR 2017JCR 2017
JCR 2017
 
Getting Biopharmaceutical Production Processes Right the First Time
Getting Biopharmaceutical Production Processes Right the First TimeGetting Biopharmaceutical Production Processes Right the First Time
Getting Biopharmaceutical Production Processes Right the First Time
 
Understanding and Controlling Bioprocess Variation | Parker domnick hunter
Understanding and Controlling Bioprocess Variation | Parker domnick hunterUnderstanding and Controlling Bioprocess Variation | Parker domnick hunter
Understanding and Controlling Bioprocess Variation | Parker domnick hunter
 
Growing Food Businesses - Dr Lesley MacLeod
Growing Food Businesses - Dr Lesley MacLeodGrowing Food Businesses - Dr Lesley MacLeod
Growing Food Businesses - Dr Lesley MacLeod
 
Sartorius Cell Line Development
Sartorius Cell Line Development Sartorius Cell Line Development
Sartorius Cell Line Development
 
Bioeconomy Cluster Builder: Industrial Applications of Biomass and Processing...
Bioeconomy Cluster Builder: Industrial Applications of Biomass and Processing...Bioeconomy Cluster Builder: Industrial Applications of Biomass and Processing...
Bioeconomy Cluster Builder: Industrial Applications of Biomass and Processing...
 
Auditing of capsule, sterile production and packaging
Auditing of capsule, sterile production and packaging Auditing of capsule, sterile production and packaging
Auditing of capsule, sterile production and packaging
 
Karen cash resume_qc08262017
Karen cash resume_qc08262017Karen cash resume_qc08262017
Karen cash resume_qc08262017
 
Chap16managingqualityandproductivity 120510232225-phpapp02
Chap16managingqualityandproductivity 120510232225-phpapp02Chap16managingqualityandproductivity 120510232225-phpapp02
Chap16managingqualityandproductivity 120510232225-phpapp02
 
Chap 16 managing quality and productivity
Chap 16 managing quality and productivityChap 16 managing quality and productivity
Chap 16 managing quality and productivity
 
Industrial biotechnologies 5 b
Industrial biotechnologies 5 bIndustrial biotechnologies 5 b
Industrial biotechnologies 5 b
 
BIOCNG PLANT.pdf
BIOCNG PLANT.pdfBIOCNG PLANT.pdf
BIOCNG PLANT.pdf
 

More from KBI Biopharma

Application and Adaptation of Platform and Alternative Purification Steps to ...
Application and Adaptation of Platform and Alternative Purification Steps to ...Application and Adaptation of Platform and Alternative Purification Steps to ...
Application and Adaptation of Platform and Alternative Purification Steps to ...
KBI Biopharma
 
Host Cell Protein Analysis by Mass Spectrometry | KBI Biopharma
Host Cell Protein Analysis by Mass Spectrometry | KBI BiopharmaHost Cell Protein Analysis by Mass Spectrometry | KBI Biopharma
Host Cell Protein Analysis by Mass Spectrometry | KBI Biopharma
KBI Biopharma
 
Octet Potency Assay: Development, Qualification and Validation Strategies
Octet Potency Assay: Development, Qualification and Validation StrategiesOctet Potency Assay: Development, Qualification and Validation Strategies
Octet Potency Assay: Development, Qualification and Validation Strategies
KBI Biopharma
 
Fine-tuning your purification process: Using mechanistic modeling of chromato...
Fine-tuning your purification process: Using mechanistic modeling of chromato...Fine-tuning your purification process: Using mechanistic modeling of chromato...
Fine-tuning your purification process: Using mechanistic modeling of chromato...
KBI Biopharma
 
HIV Vaccines Process Development & Manufacturing - Pitfalls & Possibilities
HIV Vaccines Process Development & Manufacturing - Pitfalls & PossibilitiesHIV Vaccines Process Development & Manufacturing - Pitfalls & Possibilities
HIV Vaccines Process Development & Manufacturing - Pitfalls & Possibilities
KBI Biopharma
 
Calorimetry study of a mAb that precipitates upon thermal denaturation
Calorimetry study of a mAb that precipitates upon thermal denaturationCalorimetry study of a mAb that precipitates upon thermal denaturation
Calorimetry study of a mAb that precipitates upon thermal denaturation
KBI Biopharma
 
Size-Exclusion Chromatography with On-Line Light-Scattering, Absorbance, and ...
Size-Exclusion Chromatography with On-Line Light-Scattering, Absorbance, and ...Size-Exclusion Chromatography with On-Line Light-Scattering, Absorbance, and ...
Size-Exclusion Chromatography with On-Line Light-Scattering, Absorbance, and ...
KBI Biopharma
 
Effects of Additives on Reversibility of Thermal Unfolding
Effects of Additives on Reversibility of Thermal UnfoldingEffects of Additives on Reversibility of Thermal Unfolding
Effects of Additives on Reversibility of Thermal Unfolding
KBI Biopharma
 
Analysis of Aggregation, Stability, and Lot Comparability by Sedimentation Ve...
Analysis of Aggregation, Stability, and Lot Comparability by Sedimentation Ve...Analysis of Aggregation, Stability, and Lot Comparability by Sedimentation Ve...
Analysis of Aggregation, Stability, and Lot Comparability by Sedimentation Ve...
KBI Biopharma
 
New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...
New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...
New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...
KBI Biopharma
 
Online Size-Exclusion High-Performance Liquid Chromatography Light Scattering...
Online Size-Exclusion High-Performance Liquid Chromatography Light Scattering...Online Size-Exclusion High-Performance Liquid Chromatography Light Scattering...
Online Size-Exclusion High-Performance Liquid Chromatography Light Scattering...
KBI Biopharma
 
Some Biophysical Methods for Demonstrating Comparability of Conformation and ...
Some Biophysical Methods for Demonstrating Comparability of Conformation and ...Some Biophysical Methods for Demonstrating Comparability of Conformation and ...
Some Biophysical Methods for Demonstrating Comparability of Conformation and ...
KBI Biopharma
 
Limitations and Advantages in Assessing Adenovirus Homogeneity by Laser Light...
Limitations and Advantages in Assessing Adenovirus Homogeneity by Laser Light...Limitations and Advantages in Assessing Adenovirus Homogeneity by Laser Light...
Limitations and Advantages in Assessing Adenovirus Homogeneity by Laser Light...
KBI Biopharma
 
Characterizing the aggregation and conformation of protein therapeutics
Characterizing the aggregation and conformation of protein therapeuticsCharacterizing the aggregation and conformation of protein therapeutics
Characterizing the aggregation and conformation of protein therapeutics
KBI Biopharma
 
Analyzing Aggregates of Different Sizes and Types: SEC vs. Analytical Ultrace...
Analyzing Aggregates of Different Sizes and Types: SEC vs. Analytical Ultrace...Analyzing Aggregates of Different Sizes and Types: SEC vs. Analytical Ultrace...
Analyzing Aggregates of Different Sizes and Types: SEC vs. Analytical Ultrace...
KBI Biopharma
 
Some Unusual Aggregation Phenomena in Recombinant Proteins
Some Unusual Aggregation Phenomena in Recombinant ProteinsSome Unusual Aggregation Phenomena in Recombinant Proteins
Some Unusual Aggregation Phenomena in Recombinant Proteins
KBI Biopharma
 
Analyzing Aggregates by Sedimentation Velocity and Light Scattering
Analyzing Aggregates by Sedimentation Velocity and Light ScatteringAnalyzing Aggregates by Sedimentation Velocity and Light Scattering
Analyzing Aggregates by Sedimentation Velocity and Light Scattering
KBI Biopharma
 
Is Any Measurement Method Optimal for All Aggregate Sizes and Types?
Is Any Measurement Method Optimal for All Aggregate Sizes and Types? Is Any Measurement Method Optimal for All Aggregate Sizes and Types?
Is Any Measurement Method Optimal for All Aggregate Sizes and Types?
KBI Biopharma
 
Focus on aggregation: types, causes, characterization, and impact
Focus on aggregation: types, causes, characterization, and impactFocus on aggregation: types, causes, characterization, and impact
Focus on aggregation: types, causes, characterization, and impact
KBI Biopharma
 
Sensitivity and Reproducibility of Protein Aggregate Analysis by Sedimentatio...
Sensitivity and Reproducibility of Protein Aggregate Analysis by Sedimentatio...Sensitivity and Reproducibility of Protein Aggregate Analysis by Sedimentatio...
Sensitivity and Reproducibility of Protein Aggregate Analysis by Sedimentatio...
KBI Biopharma
 

More from KBI Biopharma (20)

Application and Adaptation of Platform and Alternative Purification Steps to ...
Application and Adaptation of Platform and Alternative Purification Steps to ...Application and Adaptation of Platform and Alternative Purification Steps to ...
Application and Adaptation of Platform and Alternative Purification Steps to ...
 
Host Cell Protein Analysis by Mass Spectrometry | KBI Biopharma
Host Cell Protein Analysis by Mass Spectrometry | KBI BiopharmaHost Cell Protein Analysis by Mass Spectrometry | KBI Biopharma
Host Cell Protein Analysis by Mass Spectrometry | KBI Biopharma
 
Octet Potency Assay: Development, Qualification and Validation Strategies
Octet Potency Assay: Development, Qualification and Validation StrategiesOctet Potency Assay: Development, Qualification and Validation Strategies
Octet Potency Assay: Development, Qualification and Validation Strategies
 
Fine-tuning your purification process: Using mechanistic modeling of chromato...
Fine-tuning your purification process: Using mechanistic modeling of chromato...Fine-tuning your purification process: Using mechanistic modeling of chromato...
Fine-tuning your purification process: Using mechanistic modeling of chromato...
 
HIV Vaccines Process Development & Manufacturing - Pitfalls & Possibilities
HIV Vaccines Process Development & Manufacturing - Pitfalls & PossibilitiesHIV Vaccines Process Development & Manufacturing - Pitfalls & Possibilities
HIV Vaccines Process Development & Manufacturing - Pitfalls & Possibilities
 
Calorimetry study of a mAb that precipitates upon thermal denaturation
Calorimetry study of a mAb that precipitates upon thermal denaturationCalorimetry study of a mAb that precipitates upon thermal denaturation
Calorimetry study of a mAb that precipitates upon thermal denaturation
 
Size-Exclusion Chromatography with On-Line Light-Scattering, Absorbance, and ...
Size-Exclusion Chromatography with On-Line Light-Scattering, Absorbance, and ...Size-Exclusion Chromatography with On-Line Light-Scattering, Absorbance, and ...
Size-Exclusion Chromatography with On-Line Light-Scattering, Absorbance, and ...
 
Effects of Additives on Reversibility of Thermal Unfolding
Effects of Additives on Reversibility of Thermal UnfoldingEffects of Additives on Reversibility of Thermal Unfolding
Effects of Additives on Reversibility of Thermal Unfolding
 
Analysis of Aggregation, Stability, and Lot Comparability by Sedimentation Ve...
Analysis of Aggregation, Stability, and Lot Comparability by Sedimentation Ve...Analysis of Aggregation, Stability, and Lot Comparability by Sedimentation Ve...
Analysis of Aggregation, Stability, and Lot Comparability by Sedimentation Ve...
 
New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...
New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...
New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...
 
Online Size-Exclusion High-Performance Liquid Chromatography Light Scattering...
Online Size-Exclusion High-Performance Liquid Chromatography Light Scattering...Online Size-Exclusion High-Performance Liquid Chromatography Light Scattering...
Online Size-Exclusion High-Performance Liquid Chromatography Light Scattering...
 
Some Biophysical Methods for Demonstrating Comparability of Conformation and ...
Some Biophysical Methods for Demonstrating Comparability of Conformation and ...Some Biophysical Methods for Demonstrating Comparability of Conformation and ...
Some Biophysical Methods for Demonstrating Comparability of Conformation and ...
 
Limitations and Advantages in Assessing Adenovirus Homogeneity by Laser Light...
Limitations and Advantages in Assessing Adenovirus Homogeneity by Laser Light...Limitations and Advantages in Assessing Adenovirus Homogeneity by Laser Light...
Limitations and Advantages in Assessing Adenovirus Homogeneity by Laser Light...
 
Characterizing the aggregation and conformation of protein therapeutics
Characterizing the aggregation and conformation of protein therapeuticsCharacterizing the aggregation and conformation of protein therapeutics
Characterizing the aggregation and conformation of protein therapeutics
 
Analyzing Aggregates of Different Sizes and Types: SEC vs. Analytical Ultrace...
Analyzing Aggregates of Different Sizes and Types: SEC vs. Analytical Ultrace...Analyzing Aggregates of Different Sizes and Types: SEC vs. Analytical Ultrace...
Analyzing Aggregates of Different Sizes and Types: SEC vs. Analytical Ultrace...
 
Some Unusual Aggregation Phenomena in Recombinant Proteins
Some Unusual Aggregation Phenomena in Recombinant ProteinsSome Unusual Aggregation Phenomena in Recombinant Proteins
Some Unusual Aggregation Phenomena in Recombinant Proteins
 
Analyzing Aggregates by Sedimentation Velocity and Light Scattering
Analyzing Aggregates by Sedimentation Velocity and Light ScatteringAnalyzing Aggregates by Sedimentation Velocity and Light Scattering
Analyzing Aggregates by Sedimentation Velocity and Light Scattering
 
Is Any Measurement Method Optimal for All Aggregate Sizes and Types?
Is Any Measurement Method Optimal for All Aggregate Sizes and Types? Is Any Measurement Method Optimal for All Aggregate Sizes and Types?
Is Any Measurement Method Optimal for All Aggregate Sizes and Types?
 
Focus on aggregation: types, causes, characterization, and impact
Focus on aggregation: types, causes, characterization, and impactFocus on aggregation: types, causes, characterization, and impact
Focus on aggregation: types, causes, characterization, and impact
 
Sensitivity and Reproducibility of Protein Aggregate Analysis by Sedimentatio...
Sensitivity and Reproducibility of Protein Aggregate Analysis by Sedimentatio...Sensitivity and Reproducibility of Protein Aggregate Analysis by Sedimentatio...
Sensitivity and Reproducibility of Protein Aggregate Analysis by Sedimentatio...
 

Recently uploaded

TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Lighthouse Retreat
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
ShashankRoodkee
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Colonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implicationsColonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implications
Dr Maria Tamanna
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 

Recently uploaded (20)

TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Colonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implicationsColonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implications
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 

KBI Case Studies: Process Development

  • 1. KBI Case Studies Process Development Improving Titer Toolbox for Product Quality Optimization High Throughput Process Development Using Microbioreactors High Cell Density Process
  • 2. Improving Titer Toolbox for Product Quality Optimization High Throughput Process Development Using Microbioreactors High Cell Density Process KBI Case Studies Process Development
  • 3. KBI Case Studies | Process Development Improving Titer Objective: ● Increase titer compared to the process transferred to KBI Outcome: ● Through feed and supplement optimization, KBI routinely improves titer several fold compared to the process transferred to KBI
  • 4. KBI Case Studies | Process Development Improving Titer
  • 5. Improving Titer Toolbox for Product Quality Optimization High Throughput Process Development Using Microbioreactors High Cell Density Process KBI Case Studies Process Development
  • 6. KBI Case Studies | Process Development Objective: ● Modify product quality to match a predetermined target through use of a toolbox of strategies around raw materials and process conditions Outcome: ● KBI has a toolbox of strategies to optimize galactosylation, fucosylation, mannonse-5, glycation, and charge distribution Toolbox for Product Quality Optimization
  • 7. KBI Case Studies | Process Development Toolbox for Product Quality Optimization
  • 8. Improving Titer Toolbox for Product Quality Optimization High Throughput Process Development Using Microbioreactors High Cell Density Process KBI Case Studies Process Development
  • 9. KBI Case Studies | Process Development Objective: ● Demonstrate microbioreactor scalability and shorten process development timeline by using microbioreactors Outcome: ● KBI has demonstrated scalability of ambr microbioreactors and has integrated this technology in process development workflow. Use of microbioreactors can reduce process development timeline by 1 – 2 months. High Throughput Process Development Using Microbioreactors
  • 10. KBI Case Studies | Process Development High Throughput Process Development Using Microbioreactors Days Days ViableCellDensity(10^6cells/mL) Viability(%)
  • 11. Improving Titer Toolbox for Product Quality Optimization High Throughput Process Development Using Microbioreactors High Cell Density Process KBI Case Studies Process Development
  • 12. KBI Case Studies | Process Development Objective: ● Develop high cell density processes using ATF Outcome: ● KBI has developed high cell density processes (>100 million cells/mL) with improved viability and product quality profiles. High Cell Density Process
  • 13. KBI Case Studies | Process Development High Cell Density Process
  • 14. www.kbibiopharma.com PO Box 15579 1101 Hamlin Road Durham, NC 27704 Tel: +1 919 479 9898 Contact Us